Marvell hammered as analysts slash targets after earnings miss
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
MRVL has lost 26.7% in a week, a decline roughly five times steeper than the median of its closest peers. The earnings fallout is spreading across Wall Street desks, with nine separate analyst actions arriving on Monday alone.
Wall Street pivots fast
The scale of the target cuts is striking. TD Cowen's Sean O'Loughlin downgraded MRVL to Hold from Buy and halved his price target, from $350 to $175. BofA's Vivek Arya also moved to Neutral from Buy, cutting his target from $400 to $225.
Others kept their ratings but trimmed targets sharply. RBC Capital's Srini Pajjuir stayed at Outperform but dropped his target from $425 to $250. Wells Fargo maintained Overweight but cut from $365 to $285. Needham held its Buy rating with a target of $300, down from $400. B. Riley and Cantor Fitzgerald also lowered targets, to $275 and $225 respectively.
The consensus mean target stood at $339 as of mid-October. That number will look very different once Monday's revisions are fully incorporated.
Retail attention spikes at the lows
As the stock slid, public interest surged. ORTEX alt data shows retail attention, measured by the average z-score of daily English Wikipedia views and ORTEX stock page visits, reaching 3.6 standard deviations above its 90-day average as of today. That is an attention reading, not a sentiment signal, but it marks the scale of the drawdown's visibility.
The next earnings date is 3 December, 30 days away.
Short positioning, still modest
Short interest has climbed 13.5% over the past week to 27.3 million shares, now 3.16% of free float. That is a meaningful week-on-week acceleration but leaves overall positioning light by semiconductor-sector standards. The lending market is similarly untroubled: availability stands at 8,290%, meaning the pool of borrowable shares dwarfs existing short positions many times over. Cost to borrow has actually fallen 27% over the past week to 0.23%. Shorts are building positions but face no structural friction in doing so.
Peers are also down but far less so. ALAB fell 11.2% on the day. MU shed 5.8%. CEVA dropped 4.8%. MRVL's weekly loss of 26.7% sits well above the peer median of 5.7%.
What happened to the bull case
The bull case rested on data centre sequential growth and an interconnect business expected to grow more than 50% year over year in FY27. The bear case flagged risks from any slowdown in hyperscaler capex. Post-earnings, at least two banks concluded the miss was large enough to change their stance outright.
The P/E multiple has compressed sharply. It has fallen 10.97 points over the past week to 25.0x, down 19.4 points over the past month. The EV/EBITDA multiple has dropped 3.1 points in a week to 20.1x. On the question of where sentiment stabilises, the price level that matters most is the gap between the most bearish new target ($175, TD Cowen) and where the stock closed last night at $171.41.
Stocks in this article
See the live data behind this article on ORTEX.
Open MRVL on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 17:23
- Data as of
- 3 Nov 2026, 17:22
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.